High-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.
Human Cav3.2 calcium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7106. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, FLIPR®
Human HCN1 hyperpolarization-gated ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7114. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human HCN3 hyperpolarization-gated ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7116. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human 5-HT3A Serotonin Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7117. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human NMDA (NR1/NR2A) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7120. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human NMDA (NR1/NR2B) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7121. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human Kv1.1 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7130. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kv1.2 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7132. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kv1.3 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7134. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv1.4 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7136. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv1.5 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7138. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv3.4 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7140. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kv4.2/KChIP2.2 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7142. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kv4.3 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7144. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv7.2/Kv7.3 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7147. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human TRPC1 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7163. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: Manual Patch Clamp
Human TRPC4 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7164. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: Manual Patch Clamp
Human TRPV6 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7169. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®
Human P2X2/P2X3 purinergic receptor -expressing, transiently transfected cells (HEK293). Cat#: CT7179. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human Kir6.2/SUR2A potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7183. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human Kir6.2/SUR2B potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7184. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human P2X1 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7186. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human P2X2 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7187. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch™ HT, FLIPR®
Human P2X3 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7188. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human P2X4 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7189. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
